A local Tanzania pharmaceutical company will begin producing generic anti-retroviral drugs (ARVs) in mid-2006 from a factory in the northern town of Arusha, an official with the firm announced on Monday. "We are optimistic that the locally produced ARVs will be accessible to many HIV/AIDS patients in Tanzania," Ramadhani Madabida, the managing director Tanzania Pharmaceutical Industries (TPI), told IRIN.